{"id":"W2890033749","doi":"10.1016/j.jchf.2018.05.021","title":"Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes","year":2018,"lang":"en","type":"review","venue":"JACC Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Takeda Canada; Canadian Diabetes Association; Novo Nordisk; Sanofi; Merck; Heart and Stroke Foundation of Canada; Boehringer Ingelheim; Eli Lilly and Company","keywords":"Medicine; Placebo; Relative risk; Type 2 diabetes; Internal medicine; Randomized controlled trial; Diabetes mellitus; Alogliptin; Type 2 Diabetes Mellitus; Meta-analysis; Cochrane Library; Pharmacology; Sitagliptin; Confidence interval; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001113954,0.000777921,0.003920037,0.001353599,0.0001557609,0.0009505325,0.001231208,0.0009104701,0.003488171],"category_scores_gemma":[0.001927498,0.0002970737,0.003558623,0.001487838,0.0002089795,0.0006534019,0.0004227486,0.001544364,0.0002594069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004375227,"about_ca_system_score_gemma":0.0007245534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001774338,"about_ca_topic_score_gemma":0.00441075,"domain_scores_codex":[0.9995271,0.000113764,0.000125542,0.0000644522,0.0001300472,0.00003916915],"domain_scores_gemma":[0.9988795,0.0007815729,0.0001907214,0.000014313,0.00009669014,0.00003713979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.006938101,0.000385358,0.001524722,0.1942611,0.01868708,0.000210916,0.00008823746,0.0005316743,0.001044757,0.0009369545,0.008647746,0.7667433],"study_design_scores_gemma":[0.02083681,0.009887532,0.05764782,0.2204309,0.2190195,0.002825252,0.0007682491,0.00156144,0.002931574,0.00567574,0.4580468,0.0003682701],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005620157,0.9990607,0.00002942293,0.0000605427,0.00007302615,0.000005564712,0.00002986502,0.000001558887,0.0001773768],"genre_scores_gemma":[0.005393362,0.9939268,0.0001653199,0.0002329291,0.0001224609,0.00001053799,0.00005693223,0.000001151504,0.00009044007],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003920037,"threshold_uncertainty_score":0.01166916,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03524503057917103,"score_gpt":0.3405572229931854,"score_spread":0.3053121924140144,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}